Effect of Continuous Epinephrine Infusion on Survival in Critically Ill Patients: A Meta-Analysis of Randomized Trials*

被引:17
作者
Belletti, Alessandro [1 ]
Nagy, Adam [1 ,2 ]
Sartorelli, Marianna [1 ]
Mucchetti, Marta [1 ]
Putzu, Alessandro [3 ]
Sartini, Chiara [1 ]
Morselli, Federica [1 ]
De Domenico, Pierfrancesco [1 ]
Zangrillo, Alberto [1 ,4 ]
Landoni, Giovanni [1 ,4 ]
Lembo, Rosalba [1 ]
机构
[1] IRCCS San Raffaele Sci Inst, Dept Anesthesia & Intens Care, Milan, Italy
[2] Semmelweis Univ, Karoly Racz Sch PhD Studies, Budapest, Hungary
[3] Geneva Univ Hosp, Dept Anesthesiol Pharmacol Intens Care & Emergenc, Geneva, Switzerland
[4] Univ Vita Salute San Raffaele, Milan, Italy
关键词
catecholamines; hemodynamic management; inotropes; intensive care unit; shock; vasopressors; INTERNATIONAL CONSENSUS DEFINITIONS; CLINICAL-PRACTICE GUIDELINE; SEPTIC SHOCK; CARDIOGENIC-SHOCK; NOREPINEPHRINE; DOBUTAMINE; MANAGEMENT; SEPSIS; VASOPRESSOR; INOTROPES;
D O I
10.1097/CCM.0000000000004127
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: Epinephrine is frequently used as an inotropic and vasopressor agent in critically ill patients requiring hemodynamic support. Data from observational trials suggested that epinephrine use is associated with a worse outcome as compared with other adrenergic and nonadrenergic vasoactive drugs. We performed a systematic review and meta-analysis of randomized controlled trials to investigate the effect of epinephrine administration on outcome of critically ill patients. Data Sources: PubMed, EMBASE, and Cochrane central register were searched by two independent investigators up to March 2019. Study Selection: Inclusion criteria were: administration of epinephrine as IV continuous infusion, patients admitted to an ICU or undergoing major surgery, and randomized controlled trials. Studies on epinephrine administration as bolus (e.g., during cardiopulmonary resuscitation), were excluded. The primary outcome was mortality at the longest follow-up available. Data Extraction: Two independent investigators examined and extracted data from eligible trials. Data Synthesis: A total of 5,249 studies were assessed, with a total of 12 studies (1,227 patients) finally included in the meta-analysis. The majority of the trials were performed in the setting of septic shock, and the most frequent comparator was a combination of norepinephrine plus dobutamine. We found no difference in all-cause mortality at the longest follow-up available (197/579 [34.0%] in the epinephrine group vs 219/648 [33.8%] in the control group; risk ratio = 0.95; 95% CI, 0.82-1.10; p = 0.49; I-2 = 0%). No differences in the need for renal replacement therapy, occurrence rate of myocardial ischemia, occurrence rate of arrhythmias, and length of ICU stay were observed. Conclusions: Current randomized evidence showed that continuous IV administration of epinephrine as inotropic/vasopressor agent is not associated with a worse outcome in critically ill patients.
引用
收藏
页码:398 / 405
页数:8
相关论文
共 39 条
[1]   Lactate Elevation During and After Major Cardiac Surgery in Adults: A Review of Etiology, Prognostic Value, and Management [J].
Andersen, Lars W. .
ANESTHESIA AND ANALGESIA, 2017, 125 (03) :743-752
[2]   Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock:: a randomised trial [J].
Annane, Djillali ;
Vignon, Philippe ;
Renault, Alain ;
Bollaert, Pierre-Edouard ;
Charpentier, Claire ;
Martin, Claude ;
Troche, Gilles ;
Ricard, Jean-Damien ;
Nitenberg, Gerard ;
Papazian, Laurent ;
Azoulay, Elie ;
Bellissant, Eric .
LANCET, 2007, 370 (9588) :676-684
[3]  
[Anonymous], 2014, Cochrane handbook for systematic reviews of interventions version 5.1.0
[4]   Use of inotropes and vasopressor agents in critically ill patients [J].
Bangash, Mansoor N. ;
Kong, Ming-Li ;
Pearse, Rupert M. .
BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (07) :2015-2033
[5]  
Biondi-Zoccai G, 2011, HEART LUNG VESSEL, V3, P161
[6]   Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine [J].
Cecconi, Maurizio ;
De Backer, Daniel ;
Antonelli, Massimo ;
Beale, Richard ;
Bakker, Jan ;
Hofer, Christoph ;
Jaeschke, Roman ;
Mebazaa, Alexandre ;
Pinsky, Michael R. ;
Teboul, Jean Louis ;
Vincent, Jean Louis ;
Rhodes, Andrew .
INTENSIVE CARE MEDICINE, 2014, 40 (12) :1795-1815
[7]  
Greco T, 2013, HEART LUNG VESSEL, V5, P219
[8]   The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting [J].
Heringlake, Matthias ;
Wernerus, Marit ;
Gruenefeld, Julia ;
Klaus, Stephan ;
Heinze, Hermann ;
Bechtel, Matthias ;
Bahlmann, Ludger ;
Poeling, Jochen ;
Schoen, Julika .
CRITICAL CARE, 2007, 11 (02)
[9]   The Cochrane Collaboration's tool for assessing risk of bias in randomised trials [J].
Higgins, Julian P. T. ;
Altman, Douglas G. ;
Gotzsche, Peter C. ;
Jueni, Peter ;
Moher, David ;
Oxman, Andrew D. ;
Savovic, Jelena ;
Schulz, Kenneth F. ;
Weeks, Laura ;
Sterne, Jonathan A. C. .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
[10]   Pharmacotherapy Update on the Use of Vasopressors and Inotropes in the Intensive Care Unit [J].
Jentzer, Jacob C. ;
Coons, James C. ;
Link, Christopher B. ;
Schmidhofer, Mark .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2015, 20 (03) :249-260